Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer
2018 · Nature Medicine · 447 citations
https://doi.org/10.1038/s41591-018-0007-9
S
Shuai Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
607
Papers
11.7K
Citations
53
h-index
183
i10-index
Shuai Li is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Epigenetics and DNA Methylation & Lung Cancer Treatments and Mutations & AI in cancer detection. The author has an h-index of 53, co-authored 516 publications.
ORCID: 0000-0002-8696-8594Papers by this author
worksAvoiding dynastic, assortative mating, and population stratification biases in Mendelian randomization through within-family analyses
2020 · Nature Communications · 409 citations
https://doi.org/10.1038/s41467-020-17117-4
Avoiding dynastic, assortative mating, and population stratification biases in Mendelian randomization through within-family analyses
2020 · Nature Communications · 409 citations
https://doi.org/10.1038/s41467-020-17117-4
Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects
2022 · Nature Genetics · 377 citations
https://doi.org/10.1038/s41588-022-01062-7
Within-sibship genome-wide association analyses decrease bias in estimates of direct genetic effects
2022 · Nature Genetics · 377 citations
https://doi.org/10.1038/s41588-022-01062-7
Systemic immune inflammation index and system inflammation response index are potential biomarkers of atrial fibrillation among the patients presenting with ischemic stroke
2022 · European journal of medical research · 134 citations
https://doi.org/10.1186/s40001-022-00733-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat